Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
qxXCbn4L3f0VY6Bz